Meet the jscreen Medical and Scientific Advisory Board

Christy Tise, MD, PhD is an Assistant Professor in the Division of Medical Genetics at Stanford. She is a physician scientist and board-certified in Medical Genetics and Genomics, as well as Clinical Biochemical Genetics. Dr. Tise’s clinical areas of expertise are in biochemical genetics, perinatal genetics, and reproductive genetics. She works closely with the Perinatal Diagnostic Center (PDC) and the Reproductive Endocrinology and Infertility (REI) service on several novel and innovative initiatives, including establishing a Reproductive Genetics Clinic at Stanford to provide genetic evaluation to a wide variety of patients and families experiencing reproductive challenges. Dr. Tise’s research is focused on the genetic etiologies of recurrent pregnancy loss, the impact of inherited metabolic conditions on human reproduction, and the clinical utility of innovative technologies for diagnosis and treatment.

Dr. Melissa Frey is an Associate Professor of Obstetrics and Gynecology in the division of Gynecologic Oncology and the Director of the Genetics and Personalized Cancer Prevention Program at Weill Cornell Medicine NewYork Presbyterian Hospital. Dr. Frey’s clinical care and research focus on the management of individuals with hereditary cancer syndromes (e.g. BRCA1, BRCA2, Lynch syndrome) and family history of breast and gynecologic cancers. She performs gynecologic cancer risk-reducing surgeries and is the principal investigator on several large trials aimed at cancer prevention among high-risk individuals. Dr. Frey has presented her research at national and international meetings and has more than 150 publications in peer-reviewed scientific journals.

Robert Green, MD, MPH is a physician-scientist and Professor of Medicine at Harvard Medical School. Dr. Green directs the Genomes2People Research Program at Mass General Brigham, Ariadne Labs, and the Broad Institute. His research has demonstrated the safety, feasibility, and clinical value of returning unanticipated genetic risk information. He led the first federally funded clinical trials of genomic sequencing in healthy adults, active-duty military personnel, and infants, establishing a foundation for genomic medicine across the lifespan.

Dr. Green also led the ACMG working group that created and published the widely adopted “ACMG list” of actionable genes, and co-authored the first Global Alliance for Genomic Health policy on returning genomic results in research, helping to set global standards. He co-founded and leads the International Consortium on Newborn Sequencing, a global organization sharing data and outcomes from over 70 worldwide projects. He also serves as the lead principal investigator of the NIH-funded BRIDGES-NBS Collaboratory, the first multi-state nationwide newborn sequencing initiative in the U.S. Dr. Green has advanced real-world implementation as co-founder of the start-ups Genome Medical and Nurture Genomics, and has reached global audiences through his TED Talk on childhood screening and lifelong genomic medicine.

Jane Lowe Meisel, MD, FASCO, is a board-certified medical oncologist with a special interest in women's health and in cancers that affect women, particularly breast cancer. Her goal is to provide compassionate, exceptional, state-of-the-art care to patients and to conduct research that improves treatment options for these patients. She serves as the principal investigator for many therapeutic trials for patients with breast cancer at Winship Cancer Institute.

Dr. Meisel is a Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and the Co-Director of Breast Medical Oncology at Winship’s Glenn Family Breast Center. She completed her fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center in New York City, where she served as Chief Fellow. Prior to that, she completed her residency in internal medicine at Brigham and Women’s Hospital in Boston and received her MD from Harvard Medical School.

In addition to her roles at Emory, Dr. Meisel is a member of the Eastern Cooperative Oncology Group (ECOG) and has been a leader within the American Society of Clinical Oncology (ASCO). She has served on ASCO’s Professional Development Committee, Scientific Committee, Cancer Education Committee, and Women in Oncology Work Group. She is currently the chair of ASCO’s Cancer Communications Committee.

Michael J. Gambello, MD, PhD is Vice Chair of the Department of Human Genetics at Emory University School of Medicine and Division Director of Medical Genetics at Emory Healthcare. Dr. Gambello cares for patients and families affected with rare genetic disorders. He oversees the newborn screening follow-up program for Georgia. He leads many clinical trials for genetic disorders, does translational research, and seeks to improve accessibility to genomic medicine, including carrier screening. He has been an advisor to jscreen for 14 years. He serves on the editorial board of Genetics in Medicine and belongs to the American College of Medical Genetics and Genomics, the American Society of Human Genetics, and the Society of Inherited Metabolic Disorders.